During the past decade, CMB Collegium Medicum Berlin GmbH conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 1 clinical trials were completed, i.e. on average, 50% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 1 clinical trials were completed. i.e. 100% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "CMB Collegium Medicum Berlin GmbH" are "Atopic Dermatitis" (1 trials), "Skin Cancer" (1 trials) and "Skin Lesion" (1 trials). Many other conditions were trialed in "CMB Collegium Medicum Berlin GmbH" in a lesser frequency.

Most popular intervention types in "CMB Collegium Medicum Berlin GmbH" are "Device" (1 trials) and "Drug" (1 trials). Other intervention types were less common.

The name of intervention was led by "Cellular resolution full-field optical coherence tomography" (1 trials), "Confocal microscopy" (1 trials), "Dermoscopy imaging" (1 trials), "Optical coherence tomography imaging" (1 trials) and "Placebo" (1 trials). Other intervention names were less common.

The vast majority of trials in "CMB Collegium Medicum Berlin GmbH" are 2 trials for "All" genders.

Currently, there are NaN active trials in "CMB Collegium Medicum Berlin GmbH". undefined are not yet recruiting, 1 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in CMB Collegium Medicum Berlin GmbH, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in CMB Collegium Medicum Berlin GmbH, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".